Real talk on launch strategy— in this episode of ClearView Convos, @Jessica Lee and @Alex Lehrman join @Sam Ulin to break down what drives a successful therapeutic launch—backed by insights from conversations with seasoned biopharma leaders who are long term clients.
No shortcuts here: core launch activities remain essential, but best teams tailor their approach to the asset, the market, and the moment. Emerging technologies like precision targeting can drive best in class effectiveness and efficiency, but must be built on robust fundamentals and specifics of the target market.
From building the right teams to leveraging patient advocacy and DTC models, the conversation highlights why bespoke planning, early insights, and strong strategic partnerships are key to launch excellence.
To learn more, catch their white paper dropping later this week, or even better, join @Jessica Lee in Philly at Fierce Pharma Week (Sept 9-11) as she facilitates the Late Commercialization track, and tune in for the full convo to learn what separates good from great in commercialization:
#ClearViewConvos #ClearViewHCP #LaunchExcellence #BiopharmaStrategy
By providing my email address, I agree to ClearView's online policies